<DOC>
	<DOCNO>NCT00971503</DOCNO>
	<brief_summary>Diabetes mellitus long-term multi-organ disease severe implication constitute major health problem worldwide . Type 1 diabetes autoimmune disorder body 's immune system attack destroy cell make insulin . Exogenous administration insulin primary method control type 1 diabetes regulate blood glucose level , treatment reverse prevent disease progression . Our hypothesis implanting stimulate total bone marrow arterial injection directly pancreas , achieve functional recovery insulin-producing cell . This study include patient chronic type 1 diabetes absence lesion target organ . We follow evolution patient receive autologous total bone marrow implantation selective catheterization compare non-treatment control group . All subject continue use insulin therapy need maintain best possible glucose control . The objective achieve significant increase C-peptide level indicate regeneration beta islet cell decrease exogenous insulin usage least 70 % patient . This study follow-up initial study 22 patient receive autologous total bone marrow . The initial study 100 % safe additional study like one described need show efficacy .</brief_summary>
	<brief_title>Safety Efficacy Arterial Delivery Autologous Bone Marrow Cells Treatment Insulin-Dependent Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Between 1830 year age , diagnose diabetes mellitus Type 1 ( insulindependent ) . Negative antibody titer GAD antiislet . Measurements serum Cpeptide normal value . BMI 2025 , men , 1924 , woman Diabetes type 2 , gestational diabetes , type secondary diabetes . Patients acute metabolic complication diabetes ketoacidosis least within last 6 month . Abdominal perimeter &gt; 102 cm men ; &gt; 88cm woman Fasting glycemia &gt; 100 mg/dl , triglycerides &gt; 150 mg/dl , HDL &lt; 40 mg/dl . Blood pressure : SBP &gt; 135 mmHg DBP &gt; 85 mmHg time randomization Patients BMI &gt; 25 men &gt; 24 woman . Patients weigh &lt; 40 kg . Patients abnormal ECG indicative acute chronic ischemia acute/chronic necrosis . Patients anemias origin . Patients undergoing antibiotic treatment acute infection . Patients blood abnormality . Patients history moderate severe pancreatitis . A female subject breastfeeding , pregnant , intend become pregnant refuse use contraceptive method course study . Patients allergic iodine filgrastim . Patients use medication could affect study . Patients serious mental condition . Patients undergo previous stem cell treatment . Patients accept sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Diabetes type 1</keyword>
	<keyword>Adult Stem cell</keyword>
	<keyword>Local injection</keyword>
	<keyword>Catheter delivery</keyword>
	<keyword>Bone marrow</keyword>
</DOC>